Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

NCT03232177 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Thrombocythemia

Interventions

DRUG: Anagre Cap.

Sponsor

Yuhan Corporation